rating: 0+x

Item #: SCP-XXXX

Object Class: Euclid Safe

Special Containment Procedures: SCP-XXXX is to be held at Site-64 in a standard 3x3x2 11x11x11 meter containment chamber in E Wing with no rooms above or below it, following Incident XXXX-C. Research proposals must be approved by Head Researcher Thompson. A blind staff member must be present during all research, to safely close the object. As of 2017/11/21, research on SCP-XXXX is no longer permitted, as per the order of Site Director Holman.

Description: SCP-XXXX is an empty wooden coffin sized for an infant, which exhibits a lethal cognitohazardous effect upon human subjects. When a subject looks inside the coffin while it is open, they begin to cry in three phases, the first two of which last about a minute each. A subject must be able to see the inside of the coffin for the effect to take place - as such, blind people are immune to the effect. A blindfold also works, though it must block at least 90% of light to block the effect. However, once the effect of SCP-XXXX begins, the subject will continue to experience it even if they look away from the object.

In Phase I of the effect, there is only low-level tear production. Subjects are still capable of speaking, and report intense sadness. In Phase II, the subject begins to sob uncontrollably, and tear production increases. Some communication with the subject is still possible in Phase II, as they can still speak in between sobs, though not very intelligibly. In Phase III, the sobbing becomes strong enough to prevent speech, and tear production increases to levels not normally possible. Both continue to increase until the subject expires of either asphyxiation (due to the sobbing becoming strong enough to inhibit proper breathing) or drowning (due to greatly excessive tear production entering the mouth and lungs). A minute after a subject expires, their corpse disappears, even if it was moved away from SCP-XXXX. An application of Class-A amnestics before termination ends the effect with no harm to the subject. If a subject under the effect is terminated by something other than the effect, their corpse does not disappear and no further anomalous effects occur to it.

A subject terminated by the effect of SCP-XXXX reappears, ten days after expiring, alive within five meters of the object in any direction, as long as there is space. Medical testing reveals resurrected subjects to be in the same physical condition as before the effect of SCP-XXXX. Psychological testing reveals subjects who had clinical depression previous to the effect of SCP-XXXX no longer experience symptoms of depression. Subjects have no recollection between death and resurrection. However, it is clear that time passed for them as normal, as two to three doses of Class-C amnestics are required for a subject to lose recollection of their experience of the effects of SCP-XXXX.

Recovery: SCP-XXXX was originally located in the small town of ████████, in the Okanagan Valley region of British Columbia. Agent F█████, operating out of Penticton, investigated a multiple missing persons report on 2016/██/██ in the area of ████████, under the guise of a private investigator. According to residents of the town, the entire ████ family, along with the local pastor, disappeared six days prior during the funeral of ███████ ████, a ten-day-old infant who expired of [REDACTED]. Agent F█████ approached the funeral site, where SCP-XXXX was still on display on a pedestal beside the open grave meant for its burial. It was open, and Agent F█████ looked inside, at which point she began to exhibit the anomalous effects. Recognizing the anomalous nature of what she was experiencing, she radioed in to Site-64 for a containment team before expiring. Arriving ten hours later, the containment team, with the aid of a cognitohazards specialist, successfully closed SCP-XXXX with no incident, and recovered the object to Site-64 for containment.

Incident Log XXXX-A: Three days after SCP-XXXX was placed in containment, the entire ████ family appeared within the containment chamber. The pastor and infant corpse were nowhere to be found. Subjects were taken into Foundation custody and given physical and psychological examinations. ██████, the mother of the expired infant, reported having experienced symptoms consistent with post-partum depression before the funeral, but that she no longer experienced said symptoms. This was the initial discovery of SCP-XXXX's resurrection effect, and its effect on depression. After confirming that no anomalous effects lingered, subjects were amnesticized, given the cover story that they had contracted a new disease but have since been cured, and released from Foundation custody. Undercover Foundation agents in Health Insurance BC updated the subjects' medical records to corroborate the cover story.

Incident Log XXXX-B: Nine days after SCP-XXXX was placed in containment, Agent F█████ appeared within the containment chamber, confirming that a subject terminated by the object reappears after ten days. She was given physical and psychological examinations, and found to be healthy. She had no history of depression. She was offered amnestic treatment, but she refused it.

Incident Log XXXX-C: Early on in the course of experiments focused on SCP-XXXX's effect on depression, a D-Class subject reappeared not within the containment chamber, but one floor above in the A Wing medical center. Subject held a nurse hostage with medical equipment and attempted to escape Foundation custody. Site guards apprehended him and returned him to the D Wing dormitories. After this incident, research was temporarily halted while a new containment chamber with the current specifications was constructed for SCP-XXXX.

Addendum XXXX-A: On 2017/11/21, this note was sent to all Site-64 research staff by Site Director Holman:

As all subjects still alive and not amnesticized which have experienced SCP-XXXX's effects have developed PTSD related to it, I am hereby prohibiting all research on it. No point in trying to cure depression with this thing if it's just going to replace it with PTSD.
- Site Director Edgar Holman